Group 1 - Vanke A's largest shareholder, Shenzhen Metro Group, plans to provide a loan of up to 3 billion yuan to the company for repaying bond principal and interest [1] - The loan term will not exceed 36 months, with an interest rate based on the 1-year Loan Prime Rate (LPR) minus 66 basis points, currently at 2.34% [1] Group 2 - Gongchuang Turf's stock price has increased for five consecutive trading days, with a total rise of 58.00%, significantly deviating from the Shanghai Composite Index [2] - The company generates 88.62% of its revenue from overseas, and is closely monitoring the uncertain U.S. tariff policies [2] - In 2024, the revenue from leisure grass and sports grass is projected to be 2.052 billion yuan and 594 million yuan, accounting for 69.93% and 20.25% of main business revenue, respectively [2] Group 3 - Jinling Sports announced that some venues in the Scottish Premier League used the company's football competition equipment, but the impact on the company's performance is currently minimal [3] Group 4 - Filinger's stock has seen significant increases, but the completion of the control transfer remains uncertain, pending regulatory approval [4] - The company has not disclosed any major changes in its fundamentals [4] Group 5 - Huamai Technology's business is currently focused on communication infrastructure, including optical communication products and wireless communication network construction products [5] Group 6 - Longbai Group plans to repurchase shares worth 500 million to 1 billion yuan for employee stock ownership plans, with a maximum repurchase price of 24.82 yuan per share [6] Group 7 - Stone Technology intends to issue H-shares and list on the Hong Kong Stock Exchange, pending shareholder approval and regulatory approvals [7] Group 8 - ST Tianyu and its actual controller are under investigation by the CSRC for suspected information disclosure violations, but this will not significantly impact the company's operations [8][9] Group 9 - Honghui Fruits' controlling shareholder is planning a share transfer that may lead to a change in control, resulting in a temporary suspension of trading [10] Group 10 - Cambridge Technology's major shareholders plan to reduce their holdings by up to 8.0413 million shares, representing 3.00% of the total shares [11] Group 11 - Jialin Jie announced that its controlling shareholder's associates received administrative penalties unrelated to the company, which will not affect its daily operations [12] Group 12 - GAC Group reported a May automobile sales figure of 117,698 units, a year-on-year decline of 24.80% [13] - Shennong Group sold 232,800 pigs in May, generating revenue of 413 million yuan [14] - Dabeinong sold 727,600 pigs in May, with revenue of 1.248 billion yuan [15] - Tangrenshen's pig sales increased by 47.69% year-on-year in May, with total revenue rising by 44.97% [16] Group 13 - Jiacheng International signed a two-year air transport service contract with a well-known e-commerce platform, ensuring annual revenue of no less than 500 million yuan [18] Group 14 - Zhonggu Logistics' shareholders plan to reduce their holdings by up to 3% of the company's shares [20] - CITIC Guoan intends to reduce its holdings of Hubei Broadcasting shares by up to 11.37 million shares [20]

1、6天5板联化科技：公司K胺产品毛利稳定 尚未收到客户需求增加通知 联化科技发布投资者关系活动记录表公告称，公司K胺产品与客户签订长期协议，为定制加工模式。产 品定价采用成本加成法，在材料人工等成本费用上收取合理的加工费毛利，与客户签订长期的框架协 议，并根据客户的阶段性订单合理排产及时交付，产品毛利稳定。公司近期也关注到市场上公众媒体对 于公司生产氯虫苯甲酰胺的相关内容。截至目前，公司尚未收到该客户关于相关产品需求增加的通知。 因此，相关事项对公司影响有限，请各位投资人理性看待。 2、亚钾国际：因涉嫌内幕交易 监事彭志云被立案调查 亚钾国际公告称，公司监事彭志云于近日收到中国证监会出具的《立案告知书》，因涉嫌内幕交易被立 案调查。此次立案调查是针对彭志云个人的调查，与公司日常经营管理和业务活动无关，目前公司经营 一切正常。彭志云已申请辞去公司第八届监事会监事职务，其辞职需在公司股东大会选举产生新任监事 后生效。 3、三生国健：重组抗IL-1β人源化单克隆抗体注射液新药上市申请获受理 三生国健公告称，公司重组抗IL-1β人源化单克隆抗体注射液(SSGJ-613)用于急性痛风性关节炎适应症 的III期临床试验 ...

6月5日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者参 考。 【品大事】 海泰发展：拟以现金方式收购知学云控股权 预计构成重大资产重组 海泰发展公告称，公司正在筹划以现金方式购买知学云（北京）科技股份有限公司控股权，交易价格及 收购比例待进一步论证和协商。本次交易完成后，知学云将成为公司控股子公司。根据初步测算，本次 交易可能构成《上市公司重大资产重组管理办法》规定的重大资产重组。 舒泰神：注射用STSP-0601纳入优先审评程序 舒泰神公告称，子公司贝捷泰的产品注射用STSP-0601于5月26日被国家药品监督管理局药品审评中心 纳入拟优先审评品种公示名单。公示期满后，根据国家药品监督管理局药品审评中心网站信息公开显 示，于6月5日纳入优先审评品种名单，正式进入药品上市许可优先审评审批程序。 翠微股份：公司目前主营业务尚处于亏损状态 翠微股份发布股票交易异常波动公告，公司近年受零售行业市场环境、支付行业政策市场变化、以及子 公司当代商城中关村店闭店重建等因素的影响，零售业务和收单业务收入降幅较大，公司目前主营业务 尚处于亏损状态。 东方雨虹：公司及子公司获得政府补助113 ...